Lonza · 1 week ago
MSAT Engineer
Lonza is a global leader in life sciences, and they are seeking an MSAT Engineer in Bend, OR. In this role, you will be the primary process owner for commercial products, ensuring reliable manufacturing operations and driving process excellence through collaboration with cross-functional teams.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Serve as the process owner for commercial products, ensuring reliable and compliant manufacturing
Transfer processes to manufacturing suites and support commercial campaigns
Represent MSAT in project teams and communicate directly with customers
Lead technical investigations and support audits as a subject matter expert
Drive operational excellence by identifying projects to improve yield and efficiency
Perform advanced data analysis to monitor and optimize processes
Support process qualification and continuous verification activities
Qualification
Required
Bachelor's degree in engineering or related field
Strong understanding of cGMP regulations and manufacturing processes
Ability to analyze complex data and apply problem-solving techniques
Excellent communication and collaboration skills
Commitment to quality, safety, and continuous improvement
Adaptability and willingness to learn new technologies
Preferred
Experience in pharmaceutical or related industry
Benefits
Comprehensive medical, dental, and vision insurance.
Access to global benefits: https://www.lonza.com/careers/benefits
Relocation assistance available for qualified candidates and their families.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase